Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Megan Switzer

Nurse Practitioner Lexington, KY Nurse Practitioner

NPI 1881931145 CMS profile 11107276

1720 Nicholasville Rd, Suite 506, Lexington, KY 40503

Open in the dashboard

General payments

$6,014

76 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Megan Switzer of Lexington, KY is reported in the CMS Open Payments database as having received $6,014 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,075 43
2023 General $1,466 17
2022 General $231 12
2021 General $242 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Megan Switzer
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Megan Switzer were reported at $4,075. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Megan Switzer Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $242 $135 $40–$426 $132
2022 $231 $152 $48–$470 $149
2023 $1,466 $166 $54–$529 $160
2024 $0 $173 $55–$556 $164
2025 $4,075 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $3,438 29 payments
  2. Edwards Lifesciences Corporation $1,404 11 payments
  3. Boston Scientific Corporation $171 5 payments
  4. Atricure, Inc. $159 1 payment
  5. Merck Sharp & Dohme Corporation $154 8 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $153 4 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $140 2 payments
  8. Novartis Pharmaceuticals Corporation $88 5 payments
  9. Pfizer Inc. $73 3 payments
  10. Biosense Webster, Inc. $73 1 payment
  11. Other $160 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $2,944 10 payments
  2. Food and Beverage $2,940 64 payments
  3. Education $130 2 payments
Products named General payments · program years 2021–2025
  1. NAVITOR $2,690 20 payments
  2. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $777 8 payments
  3. CARDIOMEMS $701 7 payments
  4. ATRICLIP LAA EXCLUSION SYSTEM $159 1 payment
  5. VERQUVO $154 8 payments
  6. LifeVest $153 4 payments
  7. JARDIANCE $140 2 payments
  8. General - Therapies $139 3 payments
  9. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $108 2 payments
  10. VYNDAQEL $73 3 payments
  11. Other $457 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record